WASHINGTON – A Senate committee is investigating why the Food and Drug Administration long has delayed regulations aimed at increasing safety procedures at hundreds of tissue banks, despite a death last year from infected tissue. “The repeated delays, combined with FDA’s failure to articulate a… Read More
Comments for: Maine senator probes delay in tissue rules FDA needs to regulate banks, Collins says
Maine senator probes delay in tissue rules FDA needs to regulate banks, Collins says
You may also like
Maine senator probes delay in tissue rules FDA needs to regulate banks, Collins says